Cesium/Potassium
The lactic acid produced by fermentation lowers the cell pH  to be more acidic and destroys the ability of DNA and RNA to control cell division. The lactic acid simultaneously causes severe local pain as it destroys cell enzymes. Highly alkalinizing supplements such as Cesium stops tumor pain by countering the lactic acid. Cesium also directly fights against the cancerous cells by alkalinizing them. [Read more]
One of the conditions observed after cesium therapy was a striking rise in blood uric acid levels. This is caused by massive release of DNA from dead cancer cells. DNA is metabolized into uric acid. Typically the values went from 3.5 mg. to 20 mg. This has the potential to cause decreased kidney function because large amounts of uric acid appearing in kidney tubules can form crystals that block the tubules. If a large number of kidney tubules become blocked kidney function fails and uremia appears. This is easy to prevent by using the pharmaceutical drug Xyloprim (allopurinol) before and concomitantly with cesium so that excessively high values of uric acid do not develop. This might only be needed when 20 or more grams of cesium (high dosage) are being taken daily. Xyloprim lowers the blood level of uric acid by shifting the metabolism of proteins so that the body produces less uric acid, thus decreasing the blood levels of uric acid and the amount of uric acid the kidney needs to excrete.

Ionic Cesium & Potassium $122.  32 oz. (96 grams) 32 day supply



Clinical Results With Cesium Therapy

Dr. H. E. Sartori began his cesium cancer therapy program in April 1981 at Life Sciences Universal Medical Clinics in Rockville, Md. Fifty patients with widespread metastatic tumor deposits were treated. Forty-seven of these 50 patients had already completed maximal modalities of treatment, i.e. surgery, radiation, multiple courses of chemotherapy before cesium was tried. Their condition was hopeless.

Cesium chloride was given in 3 equal divided doses of 6 to 9 grams daily. Supplemental vitamin A emulsion (100,000 to 300,000 U), vitamin C (4 to 30 grams), zinc (80 to 100 mg., selenium (600 to 1200 mg.), and amygadalin (1500 mg.) were given plus other supplements. The diet consisted primarily of whole grains, vegetables, linolenic acid rich foods (flaxseed, walnut, soy, wheat germ) and other supplemented food. EDTA (chelation, dimethylsulfoxide (DMSO) and a combination of vitamins K, and magnesium salts were also given. The types of malignancies treated included 10 patients with breast cancer, 9 with colon cancer, 6 with prostate cancer, 4 had pancreatic cancer, 5 had lung cancer, 3 had liver cancer (hepatoma), 3 had lymphoma, 1 had Ewing's sarcoma of the pelvis, 1 had an adenocarcinoma and 8 had cancer from an unknown site of origin.

Approximately 50 % of patients with breast, colon, prostate, pancreas and lung cancer survived. Three patients were comatose when the therapy was initiated. Thirteen patients died in the first 2 weeks of therapy. Autopsy results in each of these 13 disclosed reduction in tumor mass size caused by cesium therapy. Also pain disappeared in all patients within 1 to 3 days after initiation of cesium therapy. This may have reflected decreased production of lactic acid by dying cancer cells.

One breast cancer patient was of considerable interest. She was comatose when cesium therapy was initiated using a feeding tube. She received 10 grams of cesium chloride three times daily. She walked out of the hospital 5 days later. Unfortunately it was not appreciated that a hip had been completely replaced by tumor tissue which disappeared with therapy. Having no bony tissue to support her weight she fell at home fracturing her neck resulting in death. The autopsy revealed no hip bone and only very small amounts of cancer tissue. This is a spectacular therapeutic result despite the tragic death.

In a group of 8 patients where the site of origin of the malignancy was unknown 2 patients died in the first 14 days and 2 more died in the first year. Four of the patients were still alive when last heard from more than a year later. Conventional cancer therapy has never produced any results like these as similar cases without a clear site of origin for cancer usually die rapidly.

A patient with lymphoma had a huge hard abdomen. He weighed 250 pounds. 120 pounds of weight was lost in the first 3 months of cesium therapy. His spleen was initially in his pelvis. This shrank to nearly normal size. The liver was enlarged to the umbilicus before therapy. This returned to normal size in 3 months. He was alive 3 years later at which time he was again taking chemotherapy.

Dr. Sartori believes that doses of cesium should not exceed 20 to 40 grams daily because of side effects of nausea and diarrhea. He felt that these results confirmed earlier results by Messiha which had suggested that large doses of cesium seemed to be more effective than low doses.

Dr. Sartori took 40 grams of cesium himself which caused only nausea and unusual sensations around the mouth believed to be related to potassium depletion. The usual dosage used in his clinic was 2 or 3 grams three times daily. When there is no remaining sign of cancer he thinks the dose can be safely reduced to .5 or 1 gram daily. Some patients on cesium develop evidence of potassium depletion so serum potassium needs to be monitored along with uric acid blood levels. Any alkali therapy changes the ph of the body toward a more alkalotic state. This causes movement of potassium into cells which may result in low serum potassium values. This movement of potassium into cells means that a person can become seriously depleted of potassium even if there is no diarrhea or vomiting.

A case of primary liver cancer (hepatoma) was treated later. She was a 39 year old school teacher who was terminal on arrival on April 25, 1984. Her liver was enlarged 1 inch below the umbilicus. She walked out of the hospital on May 10, 1984. Her liver had shrunk to 2 inches above the umbilicus. The alpha fetoprotein tumor marker for hepatoma had decreased from 39,000 units to 5000 units.

On one occasion Dr. Sartori noticed the disappearance of metastatic tumor masses within one hour of cesium therapy. Two days later wrinkles appeared in the skin where the tumor masses had been located.

Physicist A. Keith Brewer became very interested in cancer in the 1930s. He performed fundamental research on the membranes surrounding normal cells, rapidly growing cells (embryonal and cancerous) and dead tissue. The methods used by him included spectrographic, fluorescence decay patterns, and phosphorescence decay patterns of radioisotopes of potassium in nature. He felt that he was one of only a few persons who had actually studied ion transport across membranes.

His research enabled him to devise a protocol to treat cancer patients using cesium. Dr. Brewer then treated 30 patients with various cancers using cesium with all subjects surviving. The patients he treated were obviously not as sick as those in Dr. Sartori's group but his results provide further very encouraging evidence about cesium's value.

Rescuing 25 cancer victims from certain death is a remarkable accomplishment for cesium therapy. Conventional therapy for malignancies using chemotherapy and radiation has never been able to cure patients whose initial tumor has spread to another site i.e. liver, lung , brain, etc. The nearly deceased patients treated by Dr. Sartori had tumor deposits scattered all over their bodies. A sizeable number (50 %) of these patients recovered. Additionally, it is unheard of for a patient whose site of origin of a tumor remains unknown to recover. In Dr. Sartori's series 4 out of 8 such patients were alive one year later.